MELISSA ATKINS: Open Payments
NPI 1588325823 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 33 payments from 7 companies in 2025. Trend: 2023 $640 · 2024 $368 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $169 |
| Novo Nordisk Inc | 9 | $149 |
| Amgen Inc. | 6 | $99 |
| Lilly USA, LLC | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $17 |
Products named: FARXIGA, JARDIANCE, EVENITY, Ozempic, Rybelsus, AIRSUPRA, Dexcom G6 Transmitter, REPATHA.
Industry payments across MS — which companies pay providers there.
